Meropenem
CAS No. 96036-03-2
Meropenem( ICI 194660 | Merrem I.V. | SM-7338 )
Catalog No. M16855 CAS No. 96036-03-2
Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 38 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 73 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMeropenem
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.
-
DescriptionMeropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. (In Vitro):Meropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.(In Vivo):Meropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection.
-
In VitroMeropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.
-
In VivoMeropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection. Animal Model:Male Sprague-Dawley rats (250-350 g) induced acute necrotizing pancreatitis Dosage:60 mg/kg Administration:Intraperitoneal injection; once Result:Significantly reduced the incidence of pancreatic infection.
-
SynonymsICI 194660 | Merrem I.V. | SM-7338
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
Recptorβ-Lactamase| D-alanyl-D-alanine carboxypeptidase DacB
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number96036-03-2
-
Formula Weight383.46
-
Molecular FormulaC17H25N3O5S
-
Purity>98% (HPLC)
-
SolubilityWater: 8 mg/mL (20.86 mM); DMSO: 77 mg/mL (200.8 mM)
-
SMILESO=C(C(N12)=C(S[C@@H]3CN[C@H](C(N(C)C)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O
-
Chemical Name(4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Edwards JR, et al. J Antimicrob Chemother, 1995, 36 Suppl A, 1-17.
molnova catalog
related products
-
3-CPs
3-CPs (3-Carbethoxypsoralen) is a bleomycin-induced serotypic podoplanar polysaccharide in mouse lung fibrosis that belongs to the psoralen family and interferes with antibody-mediated bacterial killing.
-
Adenosine 5-monophos...
Adenosine 5'-monophosphate disodium salt (Adenosine Phosphate Disodium) is a purine nucleotide involved in ATP metabolism and is used to study the effects of ATP on cells and organisms.
-
4-Imidazoleacetic ac...
1H-Imidazole-5-acetic Acid Hydrochloride an imidazole derivative with potential antituberculosis properties. It also used in the preparation of acyl guanidine inhibitors of β-secretase.
Cart
sales@molnova.com